Nasdaq:US$16.09 (-0.03) | HKEX:HK$25.76 (-0.04) | AIM:£2.46 (+0.04)
搜索結果
上一篇文章   |   下一篇文章
公告及新聞稿, 腫瘤學 / 免疫學 | 2006-07-04

Chi-Med plans to broaden clinical trials of its leading oncology drug candidate